Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors.
| Last: | $1.07 |
|---|---|
| Change Percent: | 4.9% |
| Open: | $1 |
| Close: | $1.02 |
| High: | $1.0747 |
| Low: | $1 |
| Volume: | 35,522 |
| Last Trade Date Time: | 02/27/2026 10:55:41 am |
| Market Cap: | $12,347,800 |
|---|---|
| Float: | 3,280,822 |
| Insiders Ownership: | N/A |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.cytomed.sg |
| Country: | SG |
| City: | Singapore |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about CytoMed Therapeutics Limited (NASDAQ: GDTC).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
